FeNO, a potential biomarker for evaluating glucocorticoids treatment and prognosis in ABPA

Autor: Zhang, Li-sha, Wu, Yi-fan, Lu, Hai-wen, Wang, Ling, Xu, Jia-yan, Gu, Shu-yi, Mao, Bei, Yu, Li, Li, Jian-xiong, Weng, Dong, Xu, Jin-fu
Zdroj: Annals of Allergy, Asthma & Immunology; 20240101, Issue: Preprints
Abstrakt: Allergic bronchopulmonary aspergillosis (ABPA) is characterized by enhanced Th2 inflammatory response. Fractional exhaled nitric oxide (FeNO) measurement has been utilized as a valuable tool in predicting the development and management of asthma, another typical Th2 inflammation. However, the clinical significance of FeNO in ABPA remains unclear.
Databáze: Supplemental Index